Literature DB >> 1970779

Thiol-mediated catalysis of nitroglycerin degradation by serum proteins. Increase in metabolism was not accompanied by S-nitrosothiol production.

S Chong1, H L Fung.   

Abstract

In vitro degradation of nitroglycerin (NTG) in human plasma has been shown to be accelerated significantly by sulfhydryl compounds. The interaction between NTG and N-acetyl-1-cysteine (NAC) in human plasma produces a pharmacologically active S-nitrosothiol, which may be responsible, at least in part, for the in vivo nitrate tolerance-reversing effect of NAC. The mechanism of this thiol-mediated NTG degradation in plasma has not been identified. In this report, we examined the catalytic activity of various plasma proteins toward NAC-mediated NTG degradation and found human serum albumin (HSA) to have the highest catalytic activity among the proteins tested. However, the dinitrate metabolite distribution ratio found with HSA (favoring the 1,3- over the 1,2-isomer) was substantially different from that observed with human plasma (where equal amounts of both dinitrates were produced). In addition, the HSA-catalyzed degradation of NTG did not lead to enhanced formation of S-nitrosothiol. These findings therefore argue against a predominant role exerted by HSA in the thiol-mediated NTG metabolism in plasma. The HSA-mediated catalysis of NTG was partially blocked by pretreatment with NAC followed by a thiol-alkylating agent, suggesting that the catalytic mechanism was due, in part, to the conversion of disulfide linkages within the HSA structure to reactive sulfhydryl groups.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970779

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  6 in total

1.  NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.

Authors:  J F Keaney; D I Simon; J S Stamler; O Jaraki; J Scharfstein; J A Vita; J Loscalzo
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 2.  Mechanisms of action of nitrates.

Authors:  K E Torfgård; J Ahlner
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

3.  Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.

Authors:  D Salvemini; A Pistelli; E Anggard
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

4.  In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols.

Authors:  J S Scharfstein; J F Keaney; A Slivka; G N Welch; J A Vita; J S Stamler; J Loscalzo
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

5.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.

Authors:  J S Stamler; D I Simon; J A Osborne; M E Mullins; O Jaraki; T Michel; D J Singel; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

6.  Antiplatelet activities of FK409, a new spontaneous NO releaser.

Authors:  Y Kita; Y Hirasawa; K Yoshida; K Maeda
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.